文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

重症患者肺微生物群预测临床结局

Lung Microbiota Predict Clinical Outcomes in Critically Ill Patients.
PubMed 文献 · Am J Respir Crit Care Med · 2020-01-01
一句话结论重症患者入ICU 24小时内迷你BAL采样显示,肺细菌负荷增高与无呼吸机天数减少独立相关(HR 0.43),肠道相关细菌检出与ARDS相关。

该前瞻性观察性队列研究在一所大学医院ICU纳入91例重症患者,入ICU 24小时内行迷你BAL采样,用微滴数字PCR和16S rRNA基因定量测序刻画肺微生物群。主要预测因子为细菌负荷、群落多样性和群落组成,主要终点为入ICU后28天无呼吸机天数。肺细菌负荷增高者无呼吸机天数更少(HR 0.43,95%CI 0.21-0.88),控制肺炎和疾病严重程度后仍显著;肺细菌群落组成可预测无呼吸机天数(P=0.003),主要由肠道相关细菌(如毛螺菌科和肠杆菌科菌种)驱动,检出肠道相关细菌还与ARDS相关。作者认为肺微生物群是重症临床变异中被忽视的来源,并可能是急性呼吸衰竭防治的新靶点。

要点

  • 入ICU 24小时内迷你BAL采样可刻画肺微生物群,细菌负荷增高者28天无呼吸机天数更少(HR 0.43,95%CI 0.21-0.88)。
  • 控制肺炎和疾病严重程度后,肺细菌负荷与无呼吸机天数的关联仍显著。
  • 肺细菌群落组成可预测无呼吸机天数(P=0.003),主要由毛螺菌科和肠杆菌科等肠道相关细菌驱动。
  • 检出肠道相关细菌还与ARDS的存在相关。
  • 作者认为肺微生物群可能是急性呼吸衰竭防治的新治疗靶点。

适用人群与场景

  • 一所大学医院ICU收治的91例重症患者,入ICU 24小时内行迷你BAL采样。

研究设计与关键结果

  • 前瞻性观察性队列研究,91例重症患者,入ICU 24小时内行迷你BAL采样,用微滴数字PCR和16S rRNA基因定量测序分析肺微生物群。
  • 主要终点为入ICU后28天无呼吸机天数;肺细菌负荷增高者无呼吸机天数更少(HR 0.43,95%CI 0.21-0.88),控制肺炎和疾病严重程度后仍显著。
  • 肺细菌群落组成预测无呼吸机天数(P=0.003),主要由毛螺菌科和肠杆菌科等肠道相关细菌驱动。
  • 检出肠道相关细菌还与ARDS的存在相关。

证据类型、等级与局限

  • 证据类型:前瞻性观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为肺微生物群是重症临床变异中被忽视的来源,并代表急性呼吸衰竭预防和治疗的新治疗靶点。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Rationale: Recent studies have revealed that, in critically ill patients, lung microbiota are altered and correlate with alveolar inflammation. The clinical significance of altered lung bacteria in critical illness is unknown.Objectives: To determine if clinical outcomes of critically ill patients are predicted by features of the lung microbiome at the time of admission.Methods: We performed a prospective, observational cohort study in an ICU at a university hospital. Lung microbiota were quantified and characterized using droplet digital PCR and bacterial 16S ribosomal RNA gene quantification and sequencing. Primary predictors were the bacterial burden, community diversity, and community composition of lung microbiota. The primary outcome was ventilator-free days, determined at 28 days after admission.Measurements and Main Results: Lungs of 91 critically ill patients were sampled using miniature BAL within 24 hours of ICU admission. Patients with increased lung bacterial burden had fewer ventilator-free days (hazard ratio, 0.43; 95% confidence interval, 0.21-0.88), which remained significant when the analysis was controlled for pneumonia and severity of illness. The community composition of lung bacteria predicted ventilator-free days (P = 0.003), driven by the presence of gut-associated bacteria (e.g., species of the Lachnospiraceae and Enterobacteriaceae families). Detection of gut-associated bacteria was also associated with the presence of acute respiratory distress syndrome.Conclusions: Key features of the lung microbiome (bacterial burden and enrichment with gut-associated bacteria) predict outcomes in critically ill patients. The lung microbiome is an understudied source of clinical variation in critical illness and represents a novel therapeutic target for the prevention and treatment of acute respiratory failure.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Dickson RP, Schultz MJ, van der Poll T, et al. Lung Microbiota Predict Clinical Outcomes in Critically Ill Patients. Am J Respir Crit Care Med. 2020. PMID: 31973575. doi:10.1164/rccm.201907-1487OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。